Over the past three years, the Covid-19 pandemic has dominated headlines and spurred scientific research, with experts around the world focusing resources and any potentially useful technology on the problem.
Monoclonal antibodies may be the new frontier in the fight against malaria, but getting the word out won’t be easy: stakeholders from government, academia, and indus.
Financial and bureaucratic barriers in the United States mean that the next generation of Covid vaccines may well be designed here, but used elsewhere.